Monoclonal Antibody Therapeutic Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Monoclonal Antibody Therapeutic Market By Product (Naked, Fusion Protein, Antibody fragment, Conjugate, Multi-specific), By Type (Human Monoclonal Antibody, Humanized Monoclonal Antibody, Chimeric Monoclonal Antibody, Murine Monoclonal Antibody), By Application (Cancer, Autoimmune Diseases, Others ),  By End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global monoclonal antibody therapeutic market size expected to be valued at USD 9,198.4 million and growing at a CAGR of 6.9% during the forecast period 2021-2026. There are around 70 monoclonal antibody products in the market by 2020 and the sales are estimated to be million which is consider as the key driver. Restrain which hung the global monoclonal antibody therapeutic are many drugs like Abagovomab, Actoxumab in phase II and still waiting for approval which can be consider as a key challenge. The biggest opportunity is opened up due to various chronic disorder hence huge growth in the global monoclonal antibody therapeutic market is been expected. Monoclonal antibodies are a type of immunotherapy that is created in a lab and consists of several copies of a single antibody. The US Food and Drug Administration has approved several monoclonal antibodies to treat inflammatory, cancer, and other disorders (FDA). Monoclonal antibodies are classified as murine, chimeric, humanised, or human, depending on the source. Murine antibodies are produced solely from a murine source, whereas chimeric antibodies have variable murine origins and constant human origins. This report studies global monoclonal antibody therapeutic market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Monoclonal Antibody Therapeutic Market

MARKET SUMMARY
-
6.9% CAGR
  • Study Period– 2021 – 2026
  • Base Year– 2020
  • CAGR– 6.9%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Monoclonal Antibody Therapeutic Market

  • The report on global monoclonal antibody therapeutic market gives historical, current and future market sizes (US$ Bn) based on product, type, application, end user, and region.
  • monoclonal antibody therapeutic market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global monoclonal antibody therapeutic market
Key Players
  • ImmunoGen, Inc.
  • Bayer AG
  • Biogen
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Amgen, Inc.
Monoclonal Antibody Therapeutic Market

Drivers And Restraints

It is noticed that the global monoclonal antibody market is influenced mainly by the number of cancer patients which is the key factor causing the monoclonal antibody market to grow. According to WHO (World Health Organization) around 18.1 million new cases have been reported and 96 million death rates have been observed due to cancer. Monoclonal antibody therapeutic market is considered to be a lifesaving innovation and the market is estimated to be valued in huge amount by 2026. 100 monoclonal antibodies have been designated as drug and 64 monoclonal antibodies have been approved by USFDA. There are a lot of pipeline drugs related to cancer waiting for the approval and that would intensify the growth of monoclonal antibody therapeutic market.


North-America got significant share

Monoclonal Antibody Therapeutic Market

North America contributed major revenue followed by Europe and Asia Pacific. In 2019, North America region accounted huge growth rate and is anticipated to grow with a forecast year. For instance, developed and established healthcare infrastructure support from the government for R&D activity may contribute the revenue growth of market. According to Centre for Disease Control and Prevention 6 in 12 adults in US have chronic disease. Europe is booming on the perspective of innovative products the market share to both together is estimated as 65%. However, it was evident that the monoclonal antibody therapeutic market gaining interest in developing nations. Asia pacific is growing on the perspective of faster growing market players which boost monoclonal antibody therapeutic market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Market Developments

  • April 2019, Outlook Therapeutics announced the U.S. FDA acceptance and activation of the Investigational New Drug (IND) application for ONS-5010, an innovative monoclonal antibody (mAb) therapeutic product candidate being developed for wet age-related macular degeneration (wet AMD), diabetic macular edema (DME) and branch retinal vein occlusion (BRVO).
  • May 2019, CASI Pharmaceuticals, a U.S. pharmaceutical company announced the signing of a license agreement for exclusive worldwide rights to the investigational anti-CD38 monoclonal antibody (Mab) TSK011010 program from Black Belt Therapeutics Limited.

Key

Key Findings of the Report


Key

Key Features of the Report

Monoclonal Antibody Therapeutic Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Monoclonal Antibody Therapeutic Market Introduction
    • Global Monoclonal Antibody Therapeutic Market – Taxonomy
    • Global Monoclonal Antibody Therapeutic Market –Definitions
      • Product
      • Type
      • Application
      • End User
  1. Global Monoclonal Antibody Therapeutic Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Monoclonal Antibody Therapeutic Market Dynamic Factors – Impact Analysis
    • Global Monoclonal Antibody Therapeutic Market – Competition Landscape
  2. Global Monoclonal Antibody Therapeutic Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Monoclonal Antibody Therapeutic Market, By Product, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Naked
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Fusion Protein
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antibody fragment
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Conjugate
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Multi-specific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Monoclonal Antibody Therapeutic Market Forecast, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Human Monoclonal Antibody
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Humanized Monoclonal Antibody
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Chimeric Monoclonal Antibody
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Murine Monoclonal Antibody
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Monoclonal Antibody Therapeutic Market Forecast, By Application, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Cancer
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Autoimmune Diseases
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Monoclonal Antibody Therapeutic Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026
    • Hospital Pharmacy
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacy
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacy
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Monoclonal Antibody Therapeutic Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Monoclonal Antibody Therapeutic Market – Opportunity Analysis Index, By Product, Type, Application, End User and Region, 2020 – 2026
  2. North America Monoclonal Antibody Therapeutic Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Naked
      • Fusion Protein
      • Antibody fragment
      • Conjugate
      • Multi-specific
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Monoclonal Antibody
      • Humanized Monoclonal Antibody
      • Chimeric Monoclonal Antibody
      • Murine Monoclonal Antibody
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Autoimmune Diseases
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • USA
      • Canada
    • North America Monoclonal Antibody Therapeutic Market – Opportunity Analysis Index, By Product, Type, Application, End User and Country, 2020 – 2026
    • North America Monoclonal Antibody Therapeutic Market Dynamics – Trends
  3. Europe Monoclonal Antibody Therapeutic Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Naked
      • Fusion Protein
      • Antibody fragment
      • Conjugate
      • Multi-specific
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Monoclonal Antibody
      • Humanized Monoclonal Antibody
      • Chimeric Monoclonal Antibody
      • Murine Monoclonal Antibody
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Autoimmune Diseases
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Monoclonal Antibody Therapeutic Market – Opportunity Analysis Index, By Product, Type, Application, End User and Country, 2020 – 2026
    • Europe Monoclonal Antibody Therapeutic Market Dynamics – Trends
  4. Asia-Pacific Monoclonal Antibody Therapeutic Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Naked
      • Fusion Protein
      • Antibody fragment
      • Conjugate
      • Multi-specific
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Monoclonal Antibody
      • Humanized Monoclonal Antibody
      • Chimeric Monoclonal Antibody
      • Murine Monoclonal Antibody
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Autoimmune Diseases
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Monoclonal Antibody Therapeutic Market – Opportunity Analysis Index, By Product, Type, Application, End User and Country, 2020 – 2026
    • Asia-Pacific Monoclonal Antibody Therapeutic Market Dynamics – Trends
  5. Latin America Monoclonal Antibody Therapeutic Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Naked
      • Fusion Protein
      • Antibody fragment
      • Conjugate
      • Multi-specific
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Monoclonal Antibody
      • Humanized Monoclonal Antibody
      • Chimeric Monoclonal Antibody
      • Murine Monoclonal Antibody
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Autoimmune Diseases
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Latin America Monoclonal Antibody Therapeutic Market – Opportunity Analysis Index, By Product, Type, Application, End User and Country, 2020 – 2026
    • Latin America Monoclonal Antibody Therapeutic Market Dynamics – Trends
  6. Middle East and Africa Monoclonal Antibody Therapeutic Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Product Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Naked
      • Fusion Protein
      • Antibody fragment
      • Conjugate
      • Multi-specific
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Human Monoclonal Antibody
      • Humanized Monoclonal Antibody
      • Chimeric Monoclonal Antibody
      • Murine Monoclonal Antibody
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Autoimmune Diseases
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Monoclonal Antibody Therapeutic Market – Opportunity Analysis Index, By Product, Type, Application, End User and Country, 2020 – 2026
    • MEA Monoclonal Antibody Therapeutic Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • ImmunoGen, Inc.
      • Bayer AG
      • Biogen
      • Hoffmann-La Roche Ltd.
      • GlaxoSmithKline Plc
      • Amgen, Inc.
      • Pfizer Inc.
      • Sanofi
      • Novartis AG
      • Merck
      • AbbVie
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

Competition Assessment

Key player’s profiles in the global monoclonal antibody therapeutic market include:

  • ImmunoGen, Inc.
  • Bayer AG
  • Biogen
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Amgen, Inc.
  • Pfizer Inc.
  • Sanofi
  • Novartis AG
  • Merck
  • AbbVie

Description

The global monoclonal antibody therapeutic market size expected to be valued at USD 9,198.4 million and growing at a CAGR of 6.9% during the forecast period 2021-2026. There are around 70 monoclonal antibody products in the market by 2020 and the sales are estimated to be million which is consider as the key driver. Restrain which hung the global monoclonal antibody therapeutic are many drugs like Abagovomab, Actoxumab in phase II and still waiting for approval which can be consider as a key challenge. The biggest opportunity is opened up due to various chronic disorder hence huge growth in the global monoclonal antibody therapeutic market is been expected. Monoclonal antibodies are a type of immunotherapy that is created in a lab and consists of several copies of a single antibody. The US Food and Drug Administration has approved several monoclonal antibodies to treat inflammatory, cancer, and other disorders (FDA). Monoclonal antibodies are classified as murine, chimeric, humanised, or human, depending on the source. Murine antibodies are produced solely from a murine source, whereas chimeric antibodies have variable murine origins and constant human origins. This report studies global monoclonal antibody therapeutic market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX